Subscribe to RSS
DOI: 10.4103/wjnm.WJNM_86_19
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for preoperative planning in a rare case of hyperfunctional bilateral adrenocortical carcinoma and review of literatures
Abstract
Adrenal cortical carcinoma (ACC) is a rare aggressive endocrine tumor with poor prognosis. About 60% of ACC are functional tumors. Bilateral ACC is extremely rare, roughly 2%—10% of cases. Diagnosis and staging of ACC by imaging modalities are crucial for preoperative planning and prognostication. Detection of hyperfunctional bilateral adrenocortical carcinoma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F- FDG PET/CT) has never been reported. Herein, we report a male patient who presented with Cushing's syndrome, type II diabetes mellitus due to Cushing's syndrome, and hypogonadism with biopsy confirmed left ACC. He underwent 18F-FDG PET/CT to evaluate the contralateral adrenal mass and to plan for laparoscopic adrenalectomy, which subsequently confirmed bilateral ACC. Furthermore,18F-FDG PET/CT was useful in staging, which revealed paraaortic lymph node and lung metastasis.
Keywords
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography - adrenal cortical carcinoma - bilateral - Cushing's syndrome - laparoscopic adrenalectomyFinancial support and sponsorship
The research authors (Apichaya Claimon and Ngoentra Tantranont) received a Chalermphrakiat grant from the Faculty of Medicine, Siriraj Hospital, Mahidol University.
Publication History
Received: 27 November 2019
Accepted: 10 February 2020
Article published online:
19 April 2022
© 2020. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Allolio B, Fassnacht M. Clinical review: Adrenocortical carcinoma: Clinical update. J Clin Endocrinol Metab 2006;91:2027-37.
- 2 Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB, et al. Adrenocortical carcinoma: The range of appearances on CT and MRI. AJR Am J Roentgenol 2011;196:W706-14.
- 3 Cistaro A, Niccoli Asabella A, Coppolino P, Quartuccio N, Altini C, Cucinotta M, et al. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies — A multicenter experience. Hell J Nucl Med 2015;18:97-102.
- 4 Daga G, Sharma S, Mittal V. Bilateral aldosterone-producing adrenocortical carcinoma: A rare entity. Indian J Surg Oncol 2017;8:88-90.
- 5 Didolkar MS, Bescher RA, Elias EG, Moore RH. Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients. Cancer 1981;47:2153-61.
- 6 Libé R, Jazeron JF, Louiset E, Groussin L. 18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease. Endocrine 2019;63:188-9.
- 7 Beom SH, Lee KW, Yang Y, Choi Y, Song KH, Kim YJ, et al. Metastatic adrenocortical carcinoma presenting simultaneously with Cushing's and Conn's syndromes: A case report. Jpn J Clin Oncol 2011;41:1287-91.
- 8 Kostiainen I, Hakaste L, Kejo P, Parviainen H, Laine T, Löyttyniemi E, et al. Adrenocortical carcinoma: Presentation and outcome of a contemporary patient series. Endocrine 2019;65:166-74.